ArticleBMC cancer2016

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.

Kristina Magnusson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.